Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cross-reactivity and tolerability of ertapenem in patients with IgE-mediated allergy to β-lactams
2009-017828-54Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ertapenem in drug allergy, sponsored by Policlinico Gemelli. Primary endpoint: Allergic reactions to ertapenem. Started Feb 2010; status: completed.
02
Drugs
ertapenem
03
Conditions
drug allergy
Beyond the preview
Go deeper on 2009-017828-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017828-54.